Core C Protein Phenotype of Aging
- Institution
- University of Washington, WA
- Principal investigator
- Michael Maccoss
- Funding
- $212K
- Duration
- 1997–2030
Moonbase score
Still being scored
Abstract
CORE C: PROTEIN PHENOTYPES OF AGING – SUMMARY This Core is designed to support to the Aging Research Community by providing access to state-of-the-art proteomics technologies. The University of Washington Nathan Shock Center has been at the forefront of developing technologies to perform large-scale discovery-based and targeted proteomics assays that generate near complete data matrices, accurate quantitation, and high reproducibility – even across multiple laboratories. The primary goal of Core C is to apply these methods to studies of aging, to obtain accurate quantitative measurements of peptides from samples provided by its users, and to aid geroscience researchers in linking these high-dimensional data to biologically meaningful outcomes. In addition, the Core will develop and apply new assays especially suited to aging. This Core will work closely with Core D (Metabolic Phenotypes of Aging), Core E (Invertebrate Models of Aging), and Core F (Explainable Artificial Intelligence for Aging). We will collaborate with other NSCs and the broader aging research community as we have in the past. In doing this, we will assist in the discovery of proteomic changes that underlie the biology of aging and establish, disseminate, and aid in the implementation of new proteomics tools that allow us to advance studies of aging. Furthermore, we will collect proteomics data that can be used to create biological aging clocks and identify biomarkers that are associated with aging phenotypes.
LOADING MOONBASE SCORE
Questions for University of Washington
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of WashingtonNot yet scored
Seattle Quant: A Resource for the Skyline Software Ecosystem
Michael Maccoss · $1.1M · 2021–2026
- NIH · University of Washington66
NextGen Long-acting and targeted combination ART for Children with HIV
Rodney J.Y. Ho · $1.4M · 2020–2026
- NIH · University of Washington63
TLR7/8 agonist design and delivery for effective anticancer immune response
Jayanth Panyam · $350K · 2021–2026